Susquehanna International Group, LLP Cor Medix Inc. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Cor Medix Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 26,727 shares of CRMD stock, worth $286,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,727

Previous 222,628 87.99%

Holding current value

$286,780

Previous $1.8 Million 87.99%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$8.1 - $13.59 $1.59 Million - $2.66 Million	-195,901 Reduced 87.99%	26,727 $216,000
Q3 2024 Nov 14, 2024	SELL	$3.64 - $8.23 $527,712 - $1.19 Million	-144,976 Reduced 39.44%	222,628 $1.8 Million
Q2 2024 Aug 15, 2024	BUY	$4.08 - $6.39 $659,907 - $1.03 Million	161,742 Added 78.57%	367,604 $1.59 Million
Q1 2024 May 07, 2024	BUY	$2.94 - $4.24 $59,764 - $86,190	20,328 Added 10.96%	205,862 $872,000
Q4 2023 Feb 14, 2024	SELL	$3.0 - $4.01 $165,627 - $221,388	-55,209 Reduced 22.93%	185,534 $697,000
Q3 2023 Nov 14, 2023	BUY	$3.6 - $4.46 $220,413 - $273,067	61,226 Added 34.11%	240,743 $890,000
Q2 2023 Aug 11, 2023	SELL	$3.94 - $5.8 $286,863 - $422,286	-72,808 Reduced 28.85%	179,517 $710,000
Q1 2023 May 16, 2023	BUY	$3.22 - $4.61 $308,627 - $441,854	95,847 Added 61.25%	252,325 $1.04 Million
Q4 2022 Feb 14, 2023	BUY	$2.81 - $4.45 $256,468 - $406,151	91,270 Added 139.97%	156,478 $660,000
Q3 2022 Nov 14, 2022	SELL	$2.82 - $7.52 $611,923 - $1.63 Million	-216,994 Reduced 76.89%	65,208 $185,000
Q2 2022 Aug 15, 2022	BUY	$2.73 - $5.61 $482,213 - $990,922	176,635 Added 167.32%	282,202 $1.13 Million
Q1 2022 May 16, 2022	BUY	$3.83 - $6.24 $98,097 - $159,825	25,613 Added 32.03%	105,567 $579,000
Q4 2021 Feb 14, 2022	BUY	$4.47 - $5.56 $31,155 - $38,753	6,970 Added 9.55%	79,954 $364,000
Q3 2021 Nov 15, 2021	SELL	$4.46 - $7.11 $201,404 - $321,073	-45,158 Reduced 38.22%	72,984 $339,000
Q2 2021 Aug 11, 2021	SELL	$6.05 - $10.09 $395,397 - $659,431	-65,355 Reduced 35.62%	118,142 $810,000
Q1 2021 May 17, 2021	BUY	$6.84 - $17.58 $519,142 - $1.33 Million	75,898 Added 70.54%	183,497 $1.83 Million
Q4 2020 Feb 16, 2021	BUY	$5.0 - $9.15 $218,260 - $399,415	43,652 Added 68.26%	107,599 $799,000
Q3 2020 Nov 16, 2020	SELL	$3.96 - $6.15 $88,414 - $137,311	-22,327 Reduced 25.88%	63,947 $386,000
Q2 2020 Aug 14, 2020	SELL	$3.08 - $6.56 $65,810 - $140,167	-21,367 Reduced 19.85%	86,274 $544,000
Q1 2020 May 15, 2020	BUY	$2.35 - $7.08 $99,003 - $298,273	42,129 Added 64.31%	107,641 $386,000
Q4 2019 Feb 14, 2020	BUY	$4.96 - $7.75 $229,360 - $358,375	46,242 Added 239.97%	65,512 $477,000
Q3 2019 Nov 14, 2019	SELL	$6.38 - $9.69 $479,795 - $728,717	-75,203 Reduced 79.6%	19,270 $123,000
Q2 2019 Aug 16, 2019	BUY	$5.93 - $10.57 $10,389 - $18,518	1,752 Added 1.89%	94,473 $847,000
Q2 2019 Aug 14, 2019	BUY	$5.93 - $10.57 $549,835 - $980,060	92,721 New	92,721 $832,000

Others Institutions Holding CRMD

# of Institutions

135

Shares Held

21.9M

Call Options Held

599K

Put Options Held

401K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $442M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Cor Medix Inc. Transaction History